delapril
This page covers all delapril drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin-converting enzyme.
Targets
Phase 3 pipeline (1)
- Alindapril · Cardiovascular
Delapril works by blocking the action of angiotensin-converting enzyme, a protein that constricts blood vessels.
Patent intelligence
- delapril patent landscape — aggregated cliff calendar, attackable patents, originator estates